Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed

Regulatory & Legal View source PDF Explain this filing

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹517.25

prior close

₹520.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.7%-3.1% vs market

Pharmaceuticals peers, median of 158sector+1.1%-1.5% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.2

15m

-0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+2.7-3.1+1.1-1.5

Next day

-0.5-0.2-0.3-0.5+0.0

+0.3+0.7-0.3+0.2+0.2

+1.2-4.0+5.2-3.5+4.7

+2.5-1.2+3.7-2.1+4.6

+0.4+1.1-0.7+0.0+0.4

-5.0-4.6-0.4-5.0+0.1

15d

+0.7+8.3-7.6+5.7-5.0

+5.4+13.1-7.7+8.3-2.9

+7.9+14.9-7.1+11.1-3.2

+6.1+25.8-19.7+15.5-9.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amrutanjan Health Care has received an order dated March 17, 2026, from the Additional Commissioner of Central Excise & Customs (Appeals-II) under Sections 73 & 74 of the CGST Act, 2017. The order reverses Input Tax Credit claimed by the company for FY 2020-21 and 2021-22 due to a GSTR2A mismatch, with a tax demand of Rs. 24.29 lakh plus applicable interest and penalty. The company states it fulfilled all conditions under GST law and will file an appeal against the order. Management has indicated that the order does not have any major financial implications on the company.

Likely market impact

The financial impact is minimal, with the disputed tax demand being only Rs. 24.29 lakh — a small amount for the company. The order is being contested through appeal, so shareholders are unlikely to see any material effect on the stock or operations.